FTSE 100 edges towards record highs

Until the FTSE 100 breaks the historic 7,877 and 7,903 levels, investors will be fixated on each tick in the FTSE 100 and any influencing news.

As we start the third trading week of 2023, the news flow is relatively benign – and market movements muted – with US markets closed for Martin Luther King day.

This saw last week’s momentum continue into the Monday session as the FTSE 100 edged towards key historic levels of 7,877 and 7,903.

“The attractiveness of the FTSE 100 is undimmed, with the index set to flirt again with record highs in early trade. The record closing high of 7,877 is in reach, and another surge in buying could see stocks surpass the best level of 7903, seen on May 22, 2018,” said Susannah Streeter, Senior Investment and Markets Analyst, Hargreaves Lansdown

“Hopes that inflation will keep descending from its peak in the US, after encouraging data last week, saw Wall Street end on a Friday high, with positive vibes spilling over to Monday trades in Asia.”

FTSE 100 updates

There were no major updates from FTSE 100 companies on Monday after a raft of festive trading updates last week helped lift the index.

However, later in the week investors expect to receive updates from Burberry, Antofagasta, Experian and numerous other FTSE 350 companies.

China and US data

After lifting almost all COVID restrictions, China will release GDP figures and make an interest rate decision this week, which have the potential to set a tone for markets.

Investors are looking to China to help propel global growth and a strong reading will be taken well by equity market.

The US will provide more insight into their economy with retail sales for December after a robust Non-Farm Payroll number suggested resilience in labor markets.

AIM movers: Tungsten West Hemerdon update and destocking hits IQE

5

Tungsten West (LON: TUN) has updated its feasibility study for the Hemerdon tungsten and tin mine and it shows a post-tax NPV of £297m. There is a 27 year mine life. Remaining capital investment requirement for the project is £31.1m. The share price jumped 12.7% to 15.5p.

Intelligent Ultrasound (LON: IUG) 2022 revenues will be one-third higher at £10.1m. AI revenues remain small, but they have grown to £700,000. The share price moved up by 12.2% to 9.4p.

Faron Pharmaceuticals (LON: FARN) says that additional data in the study of Bexmarilimab as a treatment for haematological malignancies is encouraging. There were no additional adverse events. The share price improved by 12.2% to 9.4p.

Tracking systems developer t42 IoT Tracking Solutions (LON: TRAC) has secured a two-year agreement with an Israel-based customer for 5,000 Lokies tracking units. There will be 1,500 units supplied in the first half of 2023. The share price rose 11.5% to 7.25p.

Cannabis-based medicines developer Celadon Pharmaceuticals (LON: CEL) says that its Midlands facility has been registered with the UK Medicines and Healthcare products Regulatory Agency for manufacturing its active pharmaceutical ingredient. Celadon Pharmaceuticals has applied to the Home Office to update its existing licence. That is required to begin to supply customers. The share price rose by 8.74% to 56p.

Panther Securities (LON: PNS) is paying a special interim dividend of 10p a share. The property investor says that it expects net assets to increase by £19m in 2022, mainly due to the removal of two derivatives liabilities relating to interest rates on debt. Loan-to-value is less than 40%. Debt refinancing discussions will begin later this year. The share price increased by 10.2% to 325p.

Semiconductor wafers manufacturer IQE (LON: IQE) says that 2022 revenues will be slightly lower and the loss will be around £12m. This year will continue to be tough as inventory corrections by customers hit the first half. There could be a recovery in the second half, although bad debts are also possible. The loss should reduce this year. The share price dived 18.9% to 48.575p.

An update on the strategic review by Tekmar Group (LON: TGP) confirms that the preferred partner has been given a 14 day extension to its period of exclusivity. This relates to financing proposals and does not mean that an offer can be made by a third party. The share price slumped 15.9% to 14.5p.

Electrolyser technology developer ITM Power (LON: ITM) expects lower full year results and a higher loss. There will higher costs – particularly hitting contracts near to completion – increased warranty provisions and inventory write-downs. The new chief executive is reviewing strategy. There was £318m in the bank at the end of October 2022. This should last into 2025. The share price has been falling for two years and it declined a further 13.2% to 90.15p.

Clontarf Energy (LON: CLON) is raising £1.3m at 0.065p a share, which will nearly double the number of shares in issue. The share price slipped 9.09% to 0.075p. The cash will finance lithium projects in Bolivia and petroleum projects in Ghana and Australia.

Oil and gas company Tower Resources (LON: TRP) is raising up to $6m with a place over 24 months. The initial tranche of $1.7m will be raised at 0.36p a share – more than double the previous market price. The share price dipped 8.06% to 0.1425p. The later placings will be at an 8% discount to the five daily volume-weighted average prices for a period prior to the placing. The discount goes up to 10% after 12 months. The cash will help to finance the NJOM-3 well on the Njonji structure in the Thali PSC are in Cameroon.

ITM Power shares sink after another profit warning

ITM Power shares were suffering on Monday after the hydrogen energy solution company said results for the financial year ending April 2023 will be ‘materially different from the current guidance’ as revenue falls and EBITDA losses expand.

The ITM Power share price is now down 72% over the past 52-week period after falling 11% in early trade on Monday.

ITM attributes the poor performance to a period of testing as they move towards volume manufacturing. Write-downs, legacy contracts and underestimating certain costs are also putting pressure on earnings.

“This is the challenge I was expecting when I joined ITM,” said Dennis Schulz, ITM Power CEO

“For the Company to develop from an R&D and prototyping entity, to a mature delivery organisation, we require firmer foundations. Our 12-month plan will make ITM a stronger, more focused and highly capable company.”

“The large-scale opportunities in the market are yet to come, and by putting these foundations in place ITM will be ready for the significant market demand ahead of us.”

Another warning on profit

When a company commits to such a large scale undertaking such as revolutionising the way we generate energy and power travel, there will inevitably be growing pains. Technology from their first wave of innovation has been replaced with more efficient solutions a they seek to scale up their operations. This process has created costs that will hit profits.

Lower generation of revenue will be a concern and further insight into customer traction will be scrutinised in ITM’s interims.

ITM Power’s interim results are due 31st January when it says it will provide greater details on the strategic outlook.

Gulf Marine Services – broker reiterates Buy despite a €4m hit

The Abu Dhabi based leading provider of advanced self-propelled, self-elevating support vessels serving the offshore oil, gas and renewable industries could be taking a €4m hit to its 2022 results.

The group told shareholders that one of its clients in Europe, World Marine Offshore, has filed for bankruptcy.

Currently owed €4m on contract due to end shortly

The GMS contract with WMO, which is due to complete in Q1 2023, is to support the construction and development of a major offshore wind farm in France.

The group is currently owed about €4m but does not yet know how much of this outstanding figure may be recovered, talks with the bankruptcy trustee will ensue.

Continued strong guidance for this year

Although GMS looks to suffer somewhat, the group confidently reconfirmed to the market that its EBITDA guidance for the current year is for between $75m to $83m.

Analyst Opinion – looking for 20p a share

Analyst Daniel Slater, at the group’s corporate broker Arden Capital, considers that any negative for GMS is likely to be relatively limited overall, with the vessel concerned in the contract being easily deployed elsewhere if the contract does end early.

His estimates for the year to end December 2022 are for sales of $128.1m ($115.1m), adjusted pre-tax profits of $25.2m ($20.7m), with earnings of 1.9c (2.7c) per share.

For the year now underway his figures suggest $139.9m revenues, $29.1m profits and 2.2c per share in earnings.

The broker has a Target Price of 20p against the current market price of 4.67p, after having eased 0.385p on the news.

Conclusion – take a quick advantage

Take advantage of this quick price fall and then hold firmly as the contracts increase this year.

Totally wins major £10m new contract from challenged NHS

NHS England has commissioned Totally (LON:TLY) to provide additional call handling and clinical capacity to help to alleviate some of the pressures on local NHS 111 services, as required.

Totally helps healthcare commissioners and hospitals ensure patients can access the most appropriate care quickly and efficiently by delivering quality urgent care services, such as NHS 111 and urgent treatment centres and elective care services, such as community dermatology clinics and first contact practitioner.

It also delivers additional clinical capacity through insourcing and outsourcing arrangements to trusts and hospitals tackling growing waiting lists. Its corporate customer services also play a role in reducing reliance on healthcare by promoting healthy lifestyles and physical and mental health.

£10m pa contract with option to renew

The contract, awarded to Vocare, part of Totally’s Urgent Care division, will run from 1 March 2023 at a value of around £10m per annum, initially for one year with the option to extend for a further year.

CEO Wendy Lawrence stated that:

Totally has significant experience providing quality, resilient and responsive regional NHS 111 services. Our services have provided essential access to core healthcare services as demand has risen beyond the level anticipated by commissioners.

This new contract re-affirms Totally as a core partner in the delivery of NHS 111 services and moves to recognise the new normal in which healthcare providers are operating, providing essential additional capacity into the system.”

Analyst Opinion – 70p Target Price

James Wood at Canaccord Genuity Capital Markets rates the group’s shares as a Buy, with a Target Price of 70p.

His current year estimates, to end March, are for £140.8m (£127.4m) sales, while adjusted pre-tax profits could rise to £5.8m (£4.0m), with earnings of 3.3p (2.1p) and an unchanged dividend of 1p per share.

For the coming year Wood goes for £155m revenues, £8.0m profits, 4.4p earnings and a 1p dividend per share.

Conclusion – shares undervalued

It is very apparent that the NHS needs efficient help in providing national contingency support for its NHS 111 service and this award to Totally is an example of its potential over the next few years.

With its shares trading at around 35p they are clearly undervalued trading on 10.6 times current year earnings and on a low 7.9 times prospective.

Aquis weekly movers: KR1 recovers to November levels

Higher levels of share trading at KR1 (LON: KR1) made it the best performer last week with a 71.7% jump to 45.5p. This is the highest price since late November. There has been no news since the 1 November.

Marula Mining (LON: MARU) says graphite exploration activities have commenced at the Bagamoyo project in Tanzania. This involves mapping, sampling and trenching and should be completed in the first quarter. Marula has secured a 73% interest in the project. The share price rose 58% to 6.95p.

Chris Akers has increased his stake in Asimilar (LON: ASLR) from 6.63% to 7.41%. The share price jumped by 50.7% to 2.825p.

Tap Global (LON: TAP) completed its reversal into Quetzal Capital last week. The share price ended the week up 29.4% to 4.4p. There was £3.1m raised at 4.5p, even though the market price had not been that high since May last year. Tap Global was valued at £20.5m in the reversal and it is a crypto-fiat exchange service provider with a neo banking platform. It has gained Mastercard approval. The regulator is the Gibraltar Stock Exchange. The cash raised will be used for marketing and to grow internationally.

Wishbone Gold (LON: WSBN) has acquired a tenement covering 19 blocks in the Paterson Range in Western Australia. This cost A$50,000. The share price edged up by 2.11% to 4.85p.

==========

Fallers

Cannabis company Apollon Formularies (LON: APOL) is selling IP assets to Canada-listed Global Hemp Group for $250,000 in cash and 10 million shares in the acquiror at C$0.015 each. The first tranche of $100,000 has been paid with the rest of the cash due by the end of January. Global Hemp Group has an option to acquire the other assets of Apollon in return for 771.2 million shares. The Apollon share priced dived 14.8% to 0.66p.

NFT Investment (LON: NFT) has been hit by a cyber incident that resulted in a loss of $250,000 of assets. That is less than 1% of NAV. Further technical precautions are being investigated. The share price slumped by 10.8% to 0.825p, which values the company at £9.3m.

AIM weekly movers: Share trading surge at Light Science Technologies

2

Light Science Technologies (LON: LST) shares have been on a downward trajectory for more than one year and they reached a level where they bounced back last week. There were 785,490 shares traded on Friday, which is the most in a single day since 8 November. The share price jumped by 64.3% to 5.75p. Even so, the share price is only back to the level it was at the end of November 2022 and two-thirds lower than at the beginning of 2022.

Quantum Blockchain Technologies (LON: QBT) continued it rise following the previous Friday’s announcement that it has recruited Dr Lov Kumar Grover to help it develop methods to mine Bitcoin more cheaply and efficiently. The share price 61.5% higher at 2.1p.

Russia-focused oil and gas company Petroneft Resources (LON: PTR) has recovered some of the loss after it reported drilling delays. The share price moved up by 50% to 0.45p.

Cleantech Lithium (LON: CTL) rose 40.3% to 52.2p on the week after management made an online presentation about the business.

Velocity Composites (LON: VEL) shares improved by 38.2% to 52.5p ahead of the full year figures on 24 January.

Physiomics (LON: PYC) signed a further contract with Cancer Research UK to provide mathematical modelling for a clinical trial of a candidate for the treatment of blood cancers developed by Aleta Biotherapeutics. The project will be completed in the first quarter of 2023. The company completed an observational trial run by the University of Portsmouth that collected data from prostate cancer patients treated with docetaxel. The data will help clinicians make decisions about dosage. The share price jumped by 37.1% to 4.25p, although it had been 6.45p during the week.

==========

Fallers

Video games publisher Frontier Developments (LON: FDEV) had a poor end to 2022 and it has downgraded guidance for the year to May 2023. This is down to a poor performance by F1 Manager 2022. The share price dived 54.8% to 451.5p. Full year revenues guidance has been reduced from £135m to £100m-£114m. Interim revenues will be 16% higher at £57m and second half revenues will be lower than the corresponding period last year. Cash was £42.6m at the end of November 2022. Management is considering the future of the Frontier Foundry games label.

Customer engagement software provider Pelatro (LON: PTRO) shares fell sharply after it revealed that delayed contracts will reduce 2022 revenues. The share price was 44.1% lower on the week at 6.5p. Dowgate has reduced its 2022 revenues forecast by $2.4m to $5.8m, which means that there will be a loss of $2.6m. One licence contract is being changed to a managed services contract and revenues from another contract will be taken in 2023. Pelatro may withdraw from another contract and that would mean a $300,000 provision.

Spirits company Distil (LON: DIS) says third quarter revenues almost halved to £411,000. The removal of the UK distributor and stock reductions hit the period. Full year revenues will be worse than expected. The share price slumped by 38.8% to 0.55p.

AIM movers: Morses Club recovers and Applied Graphene stretches out cash

5

Credit provider Morses Club (LON: MCL) has recovered all of yesterday’s loss and risen 241.7% to 1.6025p. JO Hambro sold its shareholding of 8.8 million shares. It previously said it intended to vote for the proposed AIM cancelation.

Chris Akers has increased his stake in Asimilar (LON: ASLR) from 6.63% to 7.41%. The share price jumped by 26.7% to 2.85p.

Ncondezi Energy Ltd (LON: NCCL) says a transmission integration study for its solar and battery energy storage system project in Mozambique confirms it is viable to provide 300MW of power to the National grid and the wider region of Africa. This will be via a two phase approach with the first 100MW using existing infrastructure and the second phase requiring capital investment. The share price improved by 6.45% to 0.825p.

Customer engagement software provider Pelatro (LON: PTRO) shares are recovering after three days of decline following a profit warning. The share price is 8.33% higher at 6.5p, down from 12.25p prior to the announcement.

Applied Graphene Materials (LON: AGM) is continuing its discussions with potential buyers of its assets and it hopes to select a preferred party. Any deal requires shareholder approval and so it will not be completed until after the end of January. Cost savings mean that the company’s cash could last until the end of February. The share price declined by 14.4% to 6.25p.

Portable oxygen concentrator developer Belluscura (LON: BELL) has added to its distributors and commenced selling in the US. There were 1,226 units shipped during 2022 and there are orders for more than that yet to be shipped. The share price rose 9.09% to 40p.

Argentina-focused oil and gas company Echo Energy (LON: ECHO) says the 70%-owned Santa Cruz project produced 532,302 barrels of oil equivalent. Reactivation of older wells will increase production. The share price fell 8.89% to 0.1025p.

Shares in Empire Metals Ltd (LON: EEE) have fallen a further 7.79% to 1.775p after yesterday’s exploration announcement. Management says great progress has been made at Pitfield and Eclipse-Gindalbie in Western Australia. The initial phase of geochemical mapping is nearing completion.

Cancer therapies developer ValiRx (LON: VAL) has raised £1m through a placing at 11p a share and is seeking up to £500,000 more through a broker option. Every four shares come with a warrant exercisable at 14p. The cash will fund a new internal research facility. The share price dipped by 8.54% to 11.25p.

FTSE 100 heads towards all time high after UK growth surprise

The FTSE 100 was on the verge of making history on Friday as London’s leading index edged towards its all time highs.

Investors will be closely watching the index to see if the 7,877 closing high is breached today. The highest intraday level for the FTSE 100 is 7,903.

Although the FTSE 100 is poor representation of the UK economy, better than expected UK GDP figures have helped sentiment and sent the index through 7,800 to trade at 7,827 at the time of writing.

UK GDP

Fears of a UK technical recession receded on Friday after the economy expanded 0.1% in November as the services sector performer better than expected. The World Cup also boosted activity as football fans flocked to pubs for England games.

“The UK economy is doing its best to avoid falling into a technical recession with another month of growth in November. We’ll have to wait for the final quarter figures for 2022 – out next month – to confirm whether it has managed to do that,” said Ed Monk, Associate Director, Personal Investing at Fidelity International.

UK Banks

UK Banks were among top risers on Friday as investors reacted to the upbeat economic data and banking results from the US.

Lloyds shares were up 2% and approaching the key psychological level of 50p and Natwest was up 2.2%.

JP Morgan, Bank of America, Wells Fargo and Citigroup are all set to report on Friday. Those received at the time of writing were were broadly inline with estimates but Wells Fargo shares were down 4% pre-market on a $3.3bn Q4 operating loss.

JP Morgan’s EPS was better than expected.

Morses Club shares rocket with delisting now far from certain

Morses Club shares were trading a whopping 220% higher at 1.5p as their potential delisting was questioned after major shareholder sold their stake in the company.

The doorstep lender had yesterday announced a proposal to delist from AIM. For the proposals to go ahead, 75% of shareholders are required to vote for the delisting. Yesterday, the company said they had the backing of 51% of shareholders.

However, the announcement today that JO Hambro Capital Management had sold their entire stake in the company will change the dynamics dramatically and raises the question whether the 75% threshold will be met.

Morses Club shares have suffered dearly since the beginning of the pandemic and the board say delisting will provide better access to private capital.